Background: This research examines how market knowledge and artificial intelligence (AI) interact in different market designs such as business-to-business (B2B) settings while taking emerging technologies and the changing digitalization landscape into account. Objective: The main goal is to understand how AI affects market knowledge in different market designs such as business-to-business (B2B) contexts, taking into account language barriers, practical difficulties, and the revolutionary effects on decision-making and customer interactions. Result: They underscore the transformative potential of artificial intelligence (AI) by highlighting how it shapes market knowledge, encourages customized approaches, and improves marketing efficacy in the business-to-business (B2B) space. Conclusion: In order to create a path for responsible AI integration in B2B marketing, the study concludes with recommendations for standardized terminology related to AI, practical insights into implementation challenges, and ethical issues.

Background: The research is conducted against the backdrop of the rising incidence of diabetes and the demand for novel approaches to improve patient outcomes. With the goal of revolutionizing conventional methods and addressing the changing healthcare landscape, the study concentrated on the application of AI technology in diabetes treatment. Objective: Examining the various ways AI can be used in diabetes care and assessing how it can enhance automated screenings, tailored treatment recommendations, predictive modeling, and patient self-management were the main goals of the study. Result: The findings demonstrated how well AI works to anticipate a patient's unique reaction to a therapy, assist medical personnel in making decisions, and give patients more control over their own care. Artificial intelligence (AI)-powered solutions showed promise in improving real-time monitoring and encouraging patient adherence, supporting a comprehensive strategy for managing diabetes. Conclusion: The research indicates that artificial intelligence (AI) has great potential to change the way diabetes is treated. However, it also highlights the need for more research, ethical issues, and validation of AI. The results advocate for joint efforts to ensure responsible and patient-centered technology innovation in diabetes care and encourage the integration of AI with new technologies.

Ascorbate; Pars Plana Vitrectomy; Open Angle Glaucoma; Oxidative Stress; Vitreous Me-tabolism 0. How to Use This Template